3rd International Conference on Rare Diseases and Orphan Drugs (Rare Diseases 2025)

Coalesce Research Group is pleased to announce the 3rd International Conference on Rare Diseases and Orphan Drugs, set to take place on October 27–28, 2025, in Singapore City, Singapore. This two-day conference is designed to serve as a global platform for experts, stakeholders, and advocates to discuss advancements, challenges, and opportunities in the rare diseases and orphan drugs sector.

The primary objective of Rare Diseases 2025 is to raise awareness, foster collaboration, and accelerate progress in addressing the complex needs of individuals affected by rare diseases. The conference will facilitate dialogue and knowledge exchange among diverse stakeholders involved in rare disease research, drug development, patient care, advocacy, and policy-making.

The conference may cover a wide range of topics related to rare diseases and orphan drugs, including but not limited to:

• Disease epidemiology and genetics
• Advances in diagnosis and screening
• Therapeutic interventions and treatment approaches
• Drug discovery and development strategies
• Regulatory pathways and orphan drug designation
• Patient-centered care and access to treatments
• Health economics and reimbursement issues
• Patient advocacy, support, and empowerment

Rare Diseases 2025 features keynote presentations, plenary sessions, panel discussions, poster presentations, workshops and networking opportunities. It may also include exhibits showcasing the latest advancements in rare disease research, diagnostics, and therapeutics. 

Overall, Rare Diseases 2025 plays a crucial role in advancing research, innovation, and collaboration to improve outcomes and quality of life for individuals living with rare diseases